IMMY, founded in 1979, is a U.S.-based company headquartered in Norman, Oklahoma, with a focus on biotechnology, health care, and manufacturing. The company's slogan, Saving Lives One Diagnostic at a Time, encapsulates its mission to bring diagnostics closer to patients. They specialize in developing and manufacturing affordable and reliable diagnostic tests for fungal and infectious diseases.
IMMY is addressing the global issue of delayed, inaccurate, and inaccessible fungal diagnostics. Their innovative solutions empower healthcare providers by enabling early detection across a broad range of fungal pathogens, allowing for informed treatment decisions. Such capabilities are crucial in supporting quality care in over 100 countries.
With a focus on antifungal stewardship, IMMY also advocates for the responsible use of antifungal therapies. Despite its long history, the company has not disclosed any recent investment activities, indicating a potential opportunity for investors to participate in its growth and global health impact.